Log In
Print this Print this

MAb against CXCR4

  Manage Alerts
Collapse Summary General Information
Company Northwest Biotherapeutics Inc.
Description mAb against CXC chemokine receptor 4 (CXCR4)
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionCXC chemokine receptor 4 (CXCR4) antagonist; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today